Browse > Article
http://dx.doi.org/10.4014/jmb.2104.04028

Role of Interleukin-4 (IL-4) in Respiratory Infection and Allergy Caused by Early-Life Chlamydia Infection  

Li, Shujun (Department of Clinical Laboratory, People's Hospital of Xing'an League)
Wang, Lijuan (Department of Five Sense Organs, People's Hospital of Xing'an League)
Zhang, Yulong (Department of Clinical Laboratory, People's Hospital of Xing'an League)
Ma, Long (Department of Clinical Laboratory, People's Hospital of Xing'an League)
Zhang, Jing (Department of Clinical Laboratory, People's Hospital of Xing'an League)
Zu, Jianbing (Department of Clinical Laboratory, People's Hospital of Xing'an League)
Wu, Xuecheng (Department of Clinical Laboratory, Shenzhen People's Hospital)
Publication Information
Journal of Microbiology and Biotechnology / v.31, no.8, 2021 , pp. 1109-1114 More about this Journal
Abstract
Chlamydia pneumoniae is a type of pathogenic gram-negative bacteria that causes various respiratory tract infections including asthma. Chlamydia species infect humans and cause respiratory infection by rupturing the lining of the respiratory which includes the throat, lungs and windpipe. Meanwhile, the function of interleukin-4 (IL-4) in Ch. pneumoniae respiratory infection and its association with the development of airway hyperresponsiveness (AHR) in adulthood and causing allergic airway disease (AAD) are not understood properly. We therefore investigated the role of IL-4 in respiratory infection and allergy caused by early life Chlamydia infection. In this study, Ch. pneumonia strain was propagated and cultured in HEp-2 cells according to standard protocol and infant C57BL/6 mice around 3-4 weeks old were infected to study the role of IL-4 in respiratory infection and allergy caused by early life Chlamydia infection. We observed that IL-4 is linked with Chlamydia respiratory infection and its absence lowers respiratory infection. IL-4R α2 is also responsible for controlling the IL-4 signaling pathway and averts the progression of infection and inflammation. Furthermore, the IL-4 signaling pathway also influences infection-induced AHR and aids in increasing AAD severity. STAT6 also promotes respiratory infection caused by Ch. pneumoniae and further enhanced its downstream process. Our study concluded that IL-4 is a potential target for preventing infection-induced AHR and severe asthma.
Keywords
Chlamydia; respiratory infection; interleukin-4; asthma; pneumonia;
Citations & Related Records
연도 인용수 순위
  • Reference
1 Zhou F, Liu P, Lv H, Gao Z, Chang W, Xu Y. 2021. miR-31 attenuates murine allergic rhinitis by suppressing interleukin-13-induced nasal epithelial inflammatory responses. Mol. Med. Rep. 23: 42-51.
2 Furue M. 2020. Regulation of skin barrier function via competition between AHR axis versus IL-13/IL-4-JAK-STAT6/STAT3 axis: pathogenic and therapeutic implications in atopic dermatitis. J. Clin. Med. 9: 3741-3749.   DOI
3 Furue M. 2020. Regulation of filaggrin, loricrin, and involucrin by IL-4, IL-13, IL-17A, IL-22, AHR, and NRF2: pathogenic implications in atopic dermatitis. Int. J. Mol. Sci. 21: 5382-5391.   DOI
4 Mandlik DS, Mandlik SK. 2020. New perspectives in bronchial asthma: pathological, immunological alterations, biological targets, and pharmacotherapy. Immunopharmacol. Immunotoxicol. 42: 521-544.   DOI
5 Chow AW, Hall CB, Klein JO, Kammer RB, Meyer R, J S Remington. 1992. Evaluation of new anti-infective drugs for the treatment of respiratory tract infections. Infectious Diseases Society of America and the Food and Drug Administration. Clin. Infect. Dis. 15: S62-88.
6 Madden KB, Urban JF Jr, Ziltener HJ, Schrader JW, Finkelman FD, Katona IM. 1991. Antibodies to IL-3 and IL-4 suppress helminth-induced intestinal mastocytosis. J. Immunol. 147: 1387-1391.
7 Temann UA, Prasad B, Gallup MW, Basbaum C, Ho SB, Flavell RA, et al. 1997. A novel role for murine IL-4 in vivo: induction of MUC5AC gene expression and mucin hypersecretion. Am. J. Respir. Cell Mol. Biol. 16: 471-478.   DOI
8 Porritt RA, Crother TR. 2016. Chlamydia pneumoniae infection and inflammatory diseases. For. Immunopathol. Dis. Therap. 7: 237-254.   DOI
9 Miguel RDV, Harvey SA, LaFramboise WA, Reighard SD, Matthews DB, T L Cherpes. 2013. Human female genital tract infection by the obligate intracellular bacterium Chlamydia trachomatis elicits robust Type 2 immunity. PLoS One 8: e58565.   DOI
10 Stokes HS, Martens JM, Walder K, Segal Y, Berg ML, A TD Bennett. 2020. Species, sex and geographic variation in Chlamydial prevalence in abundant wild Australian parrots. Sci. Rep. 10: 20478.   DOI
11 Stokes HS, Martens JM, Jelocnik M, Walder K, Segal Y, M L Berg, et al. 2020. Chlamydial diversity and predictors of infection in a wild Australian parrot, the Crimson Rosella (Platycercus elegans). Transbound Emerg. Dis. 68: 487-498.
12 Horvat JC, Starkey MR, Kim RY, Phipps S, Gibson PG, Beagley KW, et al. 2010. Early-life chlamydial lung infection enhances allergic airways disease through age-dependent differences in immunopathology. J. Allergy Clin. Immunol. 125: 617-625.   DOI
13 Kaiko GE, Phipps S, Hickey DK, Lam CE, Hansbro PM, Foster PS, et al. 2008. Chlamydiamuridarum infection subverts dendritic cell function to promote Th2 immunity and airways hyperreactivity. J. Immunol. 180: 2225-2232.   DOI
14 Hogan SP, Mould A, Kikutani H, Ramsay AJ, Foster PS. 1997. Aeroallergen-induced eosinophilic inflammation, lung damage, and airways hyperreactivity in mice can occur independently of IL-4 and allergen-specific immunoglobulins. J. Clin. Invest. 99: 1329-1339.   DOI
15 Hahn DL, Azenabor AA, Beatty WL, Byrne GI. 2002. Chlamydia pneumoniae as a respiratory pathogen. Front. Biosci. 7: e66-76.   DOI
16 Finkelman FD, Katona IM, Urban JF Jr, Holmes J, Ohara J, Tung AS. 1988. IL-4 is required to generate and sustain in vivo IgE responses. J. Immunol. 141: 2335-2341.
17 Snodgrass RG, Benatzy Y, Schmid T, Namgaladze D, Mainka M, Schebb NH, et al. 2021. Efferocytosis potentiates the expression of arachidonate 15-lipoxygenase (ALOX15) in alternatively activated human macrophages through LXR activation. Cell Death Differ. 28: 1301-1316.   DOI
18 Butcher R, Handley B, Garae M, Taoaba R, Pickering H, Bong A, et al. 2020. Ocular Chlamydia trachomatis infection, anti-Pgp3 antibodies and conjunctival scarring in Vanuatu and Tarawa, Kiribati before antibiotic treatment for trachoma. J. Infect. 80: 454-461.   DOI
19 Ramadhani AM, Derrick T, Macleod D, Holland MJ, Burton MJ. 2016. The relationship between active trachoma and ocular Chlamydia trachomatis infection before and after mass antibiotic treatment. PLoS Negl. Trop. Dis. 10: e0005080.   DOI
20 Cheok YY, Lee CYQ, Cheong HC, Looi CY, Wong WF. 2020. Chronic inflammatory diseases at secondary sites ensuing urogenital or pulmonary Chlamydia Infections. Microorganisms 8: 127-132.   DOI
21 Jolly AL, Rau S, Chadha AK, Abdulraheem EA, Dean D. 2019. Stromal fibroblasts drive host inflammatory responses that are dependent on Chlamydia trachomatis strain type and likely influence disease outcomes. mBio 10: e00225-00239.
22 Belay T, Martin E, Brown G, Crenshaw R, Street J, Freem A, et al. 2020. Modulation of T helper 1 and T helper 2 immune balance in a murine stress model during Chlamydia muridarum genital infection. PLoS One 15: e0226539.   DOI
23 Kaiko GE, Phipps S, Hickey DK, Lam CE, Hansbro PM, Foster PS, et al. 2008. Chlamydia muridarum infection subverts dendritic cell function to promote Th2 immunity and airways hyperreactivity. J. Immunol. 180: 2225-2232.   DOI
24 Lee JS, Munoz BE, Mkocha H, Gaydos CA, Quinn TC, West SK. 2014. The effect of multiple rounds of mass drug administration on the association between ocular Chlamydia trachomatis infection and follicular trachoma in preschool-aged children. PLoS Negl. Trop. Dis. 8: e2761.   DOI
25 Razali N, Hohjoh H, Inazumi T, Maharjan BD, Nakagawa K, Konishi M, et al. 2020. Induced prostanoid synthesis regulates the balance between Th1- and Th2-producing inflammatory cytokines in the thymus of diet-restricted mice. Biol. Pharm. Bull 43: 649-662.   DOI
26 von Mutius E, Smits HH. 2020. Primary prevention of asthma: from risk and protective factors to targeted strategies for prevention. Lancet 396: 854-866.   DOI
27 Jupelli M, Guentzel MN, Meier PA, Zhong G, Murthy AK, Arulanandam BP. 2008. Endogenous IFN-gamma production is induced and required for protective immunity against pulmonary chlamydial infection in neonatal mice. J. Immunol. 180: 4148-4155.   DOI
28 Gnarpe J, Gnarpe H, Sundelof B. 1991. Endemic prevalence of Chlamydia pneumoniae in subjectively healthy persons. Scand. J. Infect. Dis. 23: 387-398.   DOI
29 Schmidt SM, Muller CE, Mahner B, Wiersbitzky SK. 2002. Prevalence, rate of persistence and respiratory tract symptoms of Chlamydia pneumoniae infection in 1211 kindergarten and school age children. Pediatr. Infect. Dis. J. 21: 758-762.   DOI
30 Yang X. 2003. Role of cytokines in Chlamydia trachomatis protective immunity and immunopathology. Curr. Pharm. Des. 9: 67-73.   DOI
31 Butcher R, Sokana O, Jack K, Sui L, Russell C, A Last, et al. 2018. Clinical signs of trachoma are prevalent among Solomon Islanders who have no persistent markers of prior infection with Chlamydia trachomatis. Wellcome Open Res. 3: 14.   DOI
32 Kalman S, Mitchell W, Marathe R, Lammel C, Fan J, Hyman RW, et al. 1999. Comparative genomes of Chlamydia pneumoniae and C. trachomatis. Nat. Genet. 21: 385-389.   DOI
33 Hansbro PM, Starkey MR, Kim RY, Stevens RL, Foster PS, Horvat JC. 2012. Programming of the lung by early-life infection. J. Dev. Orig. Health Dis. 3: 153-158.   DOI